April Thomas

Director, Biologics Strategy And Business Execution Lead at Bristol-Myers Squibb

April Thomas is an accomplished professional with extensive experience in strategic planning and project management within the pharmaceutical industry. Currently serving as the Director of Biologics Strategy and Business Execution Lead at Bristol Myers Squibb since November 2023, April is responsible for executing key strategic initiatives and enhancing network alignment. Prior to this role, April held significant positions at AstraZeneca from October 2012 to April 2023, including Director of Strategic Planning, overseeing global technical operations projects, and Associate Director of Project Management, focusing on analytical technical transfers. Additional experience at MedImmune involved project management and supervisory roles in manufacturing and packaging. April holds a Bachelor of Science in Marketing, Management, and Corporate Communications from Castleton University, an MBA from Clarkson University, and a Lean Six Sigma Black Belt Certification from Greenville Technical College.

Links

Previous companies

AstraZeneca logo